Shridhar Narayanan
Overview
Explore the profile of Shridhar Narayanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joy N, Deshpande A, Lingamallu S, Prabantu V, Naveenkumar C, Bharathkumar K, et al.
bioRxiv
. 2024 Dec;
PMID: 39713474
Airway multiciliated cells (MCs) maintain respiratory health by clearing mucus and trapped particles through the beating of motile cilia. While it is known that ciliary lengths decrease along the proximal-distal...
2.
Junk L, Schmiedel V, Guha S, Fischel K, Greb P, Vill K, et al.
Nat Commun
. 2024 Mar;
15(1):2005.
PMID: 38443338
Antimicrobial resistance is a global health threat that requires the development of new treatment concepts. These should not only overcome existing resistance but be designed to slow down the emergence...
3.
Kotimoole C, Ramya V, Kaur P, Reiling N, Shandil R, Narayanan S, et al.
J Proteome Res
. 2024 Feb;
23(3):1102-1117.
PMID: 38358903
Nontuberculous mycobacteria are opportunistic bacteria pulmonary and extra-pulmonary infections in humans that closely resemble . Although genome sequencing strategies helped determine NTMs, a common assay for the detection of coinfection...
4.
Kaur P, Krishnamurthy R, Shandil R, Mohan R, Narayanan S
Pathogens
. 2024 Jan;
13(1).
PMID: 38251347
Non-tuberculous Mycobacteria (NTM), previously classified as environmental microbes, have emerged as opportunistic pathogens causing pulmonary infections in immunocompromised hosts. The formation of the biofilm empowers NTM pathogens to escape from...
5.
Rudramurthy G, Naveenkumar C, Bharathkumar K, Shandil R, Narayanan S
Pathogens
. 2023 Nov;
12(11).
PMID: 38003792
The continuous evolution of the SARS-CoV-2 virus led to constant developments and efforts in understanding the significance and impacts of SARS-CoV-2 variants on human health. Our study aimed to determine...
6.
Putri G, Gudla C, Singh M, Ng C, Idris F, Oo Y, et al.
Antiviral Res
. 2023 Nov;
220:105739.
PMID: 37944824
With approximately 3.8 billion people at risk of infection in tropical and sub-tropical regions, Dengue ranks among the top ten threats worldwide. Despite the potential for severe disease manifestation and...
7.
Gudla C, Selvam V, Selvaraj S, Tripathi R, Joshi P, Shaham S, et al.
Pathogens
. 2023 Oct;
12(10).
PMID: 37887758
Malaria, a life-threatening mosquito-borne disease caused by parasites, continues to pose a significant global health burden. Despite notable progress in combating the disease in recent years, malaria remains prevalent in...
8.
Narayan R, Sharma M, Yadav R, Biji A, Khatun O, Kaur S, et al.
Cell Rep Med
. 2023 Jul;
4(8):101127.
PMID: 37463584
The COVID-19 pandemic highlights an urgent need for effective antivirals. Targeting host processes co-opted by viruses is an attractive antiviral strategy with a high resistance barrier. Picolinic acid (PA) is...
9.
Mehla R, Kokate P, Bhosale S, Vaidya V, Narayanan S, Shandil R, et al.
Vaccines (Basel)
. 2023 Feb;
11(2).
PMID: 36851133
Children are at risk of infection from severe acute respiratory syndrome coronavirus-2 virus (SARS-CoV-2) resulting in coronavirus disease (COVID-19) and its more severe forms. New-born infants are expected to receive...
10.
Shandil R, Dhup S, Narayanan S
Stem Cells Int
. 2022 Aug;
2022:6379161.
PMID: 35935180
Autoimmune diseases, chronic in nature, are generally hard to alleviate. Present long-term treatments with available drugs such as steroids, immune-suppressive drugs, or antibodies have several debilitating side effects. Therefore, new...